Pharmacovigilance World 2024
Online event

Pharmacovigilance World 2024

11.09.2024 - 12.09.2024 London, United Kingdom, London
Tickets
Visit the official Organizer website to ensure the accuracy of the event
Category: Medical & Pharma, Pharmaceuticals
Organizer: Corvus Global Events
Exhibition center: London

Overview interest facts - Pharmacovigilance World 2024

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.

Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.

We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.

Key Highlights:

  • Pharmacovigilance and globalization
  • Pharmacovigilance in a pandemic world
  • Women and child health care medicines and pharmacovigilance
  • Patient-centric approaches in PV
  • Pharmacovigilance legislation and regulations
  • Harmonization and pharmacovigilance
  • Advanced therapeutic techniques and pharmacovigilance
  • Pharmacovigilance and data management and eudravigilance
  • Post-marketing surveillance in pharmacovigilance
  • PV regulations and challenges
  • Benefit-risk management strategies
  • Risk management and minimization
  • Risk Evaluation and Mitigation
  • Adverse drug reactions reporting
  • Signal detection and post authorization safety
  • Good Pharmacovigilance Practices
  • Innovative approaches to drug safety
  • Strategies to improve PV
  • Real World Evidence in PV
  • Big data and AI in pharmacovigilance
  • Pharmacovigilance Workflows with AI & Automation
  • Other emerging technologies in PV

Who should attend the conference?

Attendees include GMs, VPs, Directors, Heads and Managers of:

  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Contract outsourcing service providers
  • Health outcomes
  • Sales and Marketing

News

​AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan

A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...

22 January 2024
​New material improves treatment of complex bone infections

Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...

29 November 2023
Sepsis - as common as cancer, as deadly as a heart attack

In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.

04 September 2023
​FDA approves first oral treatment for postpartum depression

Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.

10 August 2023
​New blood test finds two thirds of cancers

A new multi-cancer early detection blood test could speed up diagnosis.

16 June 2023
​EU Proposes Drug Manufacturing Overhaul, Faces Pushback

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws

04 May 2023
All news